Trial Profile

A Two-Treatment, Sequential, Crossover Study of the Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection (Infectious Rhinitis)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 10 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Oct 2024 According to an ARS Pharmaceuticals media release, data from this study will be presented on Friday, October 25 at the 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting taking place in Boston, Massachusetts.According to an ARS Pharmaceuticals media release, data from this study will be presented on Friday, October 25 at the 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting taking place in Boston, Massachusetts.
28 Jul 2022 Status changed from recruiting to completed.
02 May 2022 Planned End Date changed from 31 Mar 2022 to 10 May 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com